Macromolecules comprising a thioether cross-link
AssigneeMedImmune, LLC
InventorsGuillermo Tous, Mark Schenerman, Ziping Wei
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedImmune, LLC
InventorsGuillermo Tous, Mark Schenerman, Ziping Wei
Estimating the term…
The present invention provides macromolecules comprising at least one thioether cross-link. A thioether cross-link comprising a single thioether bond between two residues of a macromolecule. The macromolecules of the invention can display enhanced stability, pharmaceutical properties and functional properties. In particular, the invention provides an isolated antibodies comprising at least one thioether cross-link that specifically bind to particular antigens. The present invention also provides a composition comprising a macromolecule substantially free of a denaturing reagent, wherein the macromolecule comprises at least one thioether cross-link. In addition, the present invention provides a method for producing the macromolecules and compositions of the invention.
-115. (canceled)
A composition substantially free of a denaturing reagent comprising an antibody, wherein said antibody comprises at least one thioether cross-link.
A composition substantially free of a denaturing reagent comprising an antibody wherein said antibody comprises a lanthionine.
A method for increasing the amount of an antibody that comprises at least one thioether cross-link in a composition, said method comprising incubating the composition at a temperature greater than 4° C., and/or at pH greater than 7 for a time sufficient to increase the amount of said antibody comprising at least one thioether cross-link.
A method for decreasing the amount of an antibody in a composition, wherein said antibody comprises at least one thioether cross-link in a composition resulting from a first purification method, said method comprising carrying out a second purification method identical to said first purification method except that at least one step of said second purification method is carried out at a lower temperature and/or lower pH than the corresponding step in said first purification method, wherein said second purification method results in a lower level of said antibody comprising at least one thioether cross-link than said first purification method.
Dependencies are inferred from the claim text.